NewAmsterdam Pharma Company
NAMS
#4559
Rank
S$3.08 B
Marketcap
S$25.69
Share price
-3.62%
Change (1 day)
-48.48%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2026 (TTM): -S$0.31 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are S$25.93 Million. In 2025 the company made an earning of -S$0.3 Billion, an increase over its 2024 earnings that were of -S$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.31 Billion3.37%
2025 -S$0.3 Billion-7.81%
2024 -S$0.32 Billion38.38%
2023 -S$0.23 Billion